Biodexa Pharmaceuticals cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 15 quarters of results from Dec 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2013 | Dec2014 | Dec2015 | Dec2016 | Dec2017 | Dec2018 | Dec2019 | Dec2020 | Dec2021 | Dec2022 | Jun2023 | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Net Income | -7.91M | -13.98M | -15.33M | -25.07M | -6.19M | -19.34M | -12.97M | -29.30M | -7.36M | -4.38M | -4.83M | -4.57M | -5.30M | -5.50M | -2.35M |
| Cash from Discontinued Operations | 17.47M | -6.92M | |||||||||||||
| Gains from Sales and Divestitures | -0.25M | -1.75M | -1.81M | ||||||||||||
| Non-cash Items | -6.88M | -11.84M | -18.48M | -18.17M | |||||||||||
| Cash from Operations | -7.18M | -8.64M | -18.85M | 1.56M | 2.20M | -6.91M | |||||||||
| Change in Working Capital | |||||||||||||||
| Change in Receivables | -0.72M | -2.34M | -0.30M | ||||||||||||
| Change in Inventory | -0.09M | -0.29M | |||||||||||||
| Change in Account Payables | -0.53M | ||||||||||||||
| Change in Taxes | -1.29M | -1.61M | -1.72M | -11.39M | |||||||||||
| Investing Activities | |||||||||||||||
| Capital Expenditures | -0.08M | -1.63M | -1.40M | -1.67M | |||||||||||
| Change in Intangibles | -0.00M | -0.00M | -0.02M | ||||||||||||
| Acquisitions | -3.84M | ||||||||||||||
| Cash from Investing Activities | -0.08M | -1.44M | -2.33M | -0.01M | |||||||||||
| Financing Activities | |||||||||||||||
| Debt Issuance and Repayment | |||||||||||||||
| Long-Term Debt Repayments | -0.32M | -0.55M | -0.25M | -0.29M | |||||||||||
| Misc. | |||||||||||||||
| Cash from Financing Activities | -0.33M | 0.05M | -0.01M | ||||||||||||
| Exchange Rate Effect | -0.05M | ||||||||||||||
| Change in Cash | -21.51M | ||||||||||||||
| Free Cash Flow | -7.11M | -7.01M | -17.45M | 3.23M | 2.20M | -6.91M | |||||||||
| Net Cash Flow | -7.26M | -10.08M | -21.51M | 1.54M | 2.24M | -6.92M |
Pull Biodexa Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=BDRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "BDRX", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=BDRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();